301331 恩威医药
2026/09 - 九个月
人民币(K¥)
与去年末期
比较
2025/12
人民幣(K¥)
2024/12
人民幣(K¥)
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)

非流动资产
长期股权投资0--0374374352
投资性房地产24,282-6.89%26,07928,47630,87333,270
固定资产202,2372.70%196,925203,116220,638204,314
在建工程64,300-0.26%64,46540,3688,81835,684
无形资产105,388-10.14%117,283133,374148,04442,083
商誉100,5530.00%100,553100,553100,553100,553
其他非流动资产83,24519.10%69,89646,23141,33832,537
580,0040.84%575,200552,492550,638448,793

流动资产
货币资金338,150-6.67%362,306370,274236,121341,578
应收账款125,846-11.30%141,871120,24293,09698,331
存货125,79224.42%101,104115,552107,367104,646
其他流动资产267,802-27.66%370,182345,969350,276412,732
857,590-12.08%975,463952,037786,859957,287

流动负债
短期借款0--0000
应付票据0--0000
应付帐款28,856-48.91%56,48249,49330,94136,876
其他流动负债168,139-57.81%398,508188,929178,832190,708
196,995-56.70%454,990238,422209,773227,584
流动资产净值660,59526.92%520,473713,615577,086729,703
资产总额减流动负债1,240,59913.23%1,095,6731,266,1071,127,7251,178,496

非流动负债
长期借款190,000--0185,00000
应付债券0--0000
其他非流动负债21,426-6.30%22,86723,43624,53925,493
211,426824.59%22,867208,43624,53925,493

总权益
    实收股本102,8920.00%102,892102,89270,13870,138
    储备项目926,281-4.50%969,914954,7791,033,0481,082,865
股东权益1,029,173-4.07%1,072,8061,057,6711,103,1861,153,003
非控股权益0--0000